Canaccord Genuity Group Forecasts Strong Price Appreciation for Guardant Health (NASDAQ:GH) Stock
Guardant Health (NASDAQ:GH – Free Report) had its price target boosted by Canaccord Genuity Group from $60.00 to $65.00 in a research report released on Thursday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. GH has been the topic of a number of other reports. The Goldman Sachs Group boosted […]
Guardant Health (NASDAQ:GH – Free Report) had its price target boosted by Canaccord Genuity Group from $60.00 to $65.00 in a research report released on Thursday morning,Benzinga reports. Canaccord Genuity Group currently has a buy rating on the stock. GH has been the topic of a number of other reports. The Goldman Sachs Group boosted […]
